Furthermore, FAM167A and surface DSG1 levels were highly upregulated in CD34+ CML cells from patients with BCR-ABL-independent TKI-resistant disease. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.